Delivery Order SPE2DB24D3014-SPE2DB25FKUCT
- Not listed
- The Defense Logistics Agency (DLA) awarded a $15,639.75 delivery order to AmerisourceBergen Drug Corp for the supply of BOTOX Cosmetic 100 unit vials. This competitively awarded, firm fixed-price contract with no set-aside designation is expected to be completed by October 3, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $11,642.60 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of 200 unit BOTOX vials to a location in Conshohocken, Pennsylvania by March 19, 2024. This award is part of Amerisourcebergen Drug Corp's role as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Botox 100 unit vials under a firm fixed-price contract valued at $4,306.80, with an ultimate completion date of June 20, 2025. This non-set-aside, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,128.74 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 unit vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, due for completion by July 31, 2025. The award was issued on July 10, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,273.95 to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,564.37 to supply Botox 200 unit vials, with an ultimate completion date of August 20, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,227.00 to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,454.00 by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of BOTOX 200 unit vials. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, PA, with an ultimate completion date of August 26, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,613.50 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials on August 8, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $1,722.72. This firm fixed price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKUCTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,821.85 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 unit vials. This firm fixed price contract was competitively awarded without set-aside designation and is scheduled for completion by August 18, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to distribute a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical needs through the DLA Medical Supply Chain, with delivery orders involving firm fixed pricing across multiple therapeutic domains. The performance location for this delivery order is the company's corporate office in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 7/28/25 |